Development of antisense oligonucleotide drugs to supress expression of the DUX4 protein as a therapy for fascioscapulohumeral muscular dystrophy (FSHD)

Project: Research

StatusFinished
Effective start/end date1/08/1431/07/18

Funding

Rosetrees Trust: £60,000, Rosetrees Trust: £17,000

ID: 21724997